Pharmocann Global Balance Sheet Health
Financial Health criteria checks 2/6
Pharmocann Global has a total shareholder equity of ₪761.0K and total debt of ₪85.0K, which brings its debt-to-equity ratio to 11.2%. Its total assets and total liabilities are ₪7.1M and ₪6.3M respectively.
Key information
11.2%
Debt to equity ratio
₪85.00k
Debt
| Interest coverage ratio | n/a |
| Cash | ₪1.16m |
| Equity | ₪761.00k |
| Total liabilities | ₪6.34m |
| Total assets | ₪7.10m |
Recent financial health updates
No updates
Recent updates
The Returns On Capital At Pharmocann Global (TLV:PMCN) Don't Inspire Confidence
Mar 30
Should You Use Pharmocann Global's (TLV:PMCN) Statutory Earnings To Analyse It?
Feb 04Pharmocann Global Ltd (TLV:PMCN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 31
The Returns At Pharmocann Global (TLV:PMCN) Provide Us With Signs Of What's To Come
Nov 26Financial Position Analysis
Short Term Liabilities: PMCN-M's short term assets (₪5.8M) do not cover its short term liabilities (₪6.0M).
Long Term Liabilities: PMCN-M's short term assets (₪5.8M) exceed its long term liabilities (₪385.0K).
Debt to Equity History and Analysis
Debt Level: PMCN-M has more cash than its total debt.
Reducing Debt: PMCN-M's debt to equity ratio has increased from 2.8% to 11.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PMCN-M has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: PMCN-M has less than a year of cash runway if free cash flow continues to reduce at historical rates of 48.8% each year